LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...

Arena International’s Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

As scientific discovery and technology advance, new opportunities arise and business priorities shift throughout the global ...

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

While the presidential transition commanded headlines this week, equally significant shifts were occurring in AI technology. Just hours before Donald Trump’s inauguration, DeepSeek released its latest ...

Scientists at the Indian Institute of Technology Delhi recently created a new machine learning (ML)-based tool for process verification during process chromatography unit operations.

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...